Agmatine: common claims examined
A review of agmatine marketing claims, biochemical mechanisms and the small human evidence base behind proposed benefits.
A review of agmatine marketing claims, biochemical mechanisms and the small human evidence base behind proposed benefits.
Studies of oxidative stress, creatine uptake, body weight and training adaptation, with a distinction between clinical and athletic data.
An English-language overview of Ukrainian medicine regulation, named potent substances, criminal-law issues and anti-doping rules.
Proposed lipolytic mechanisms, comparison with full growth hormone and why similar structures do not establish identical safety.
The structure, long ester, androgen effects, veterinary background and uncertainties behind boldenone’s reputation in bodybuilding.
The history of clenbuterol as a bronchodilator, its veterinary applications, food-safety problems and experimental clinical research.
Estrogen feedback, isomer accumulation, hormonal effects and the limits of comparative safety evidence in men.
What is known about cholesterol, triglycerides and bone density during clomiphene use, and where direct clinical evidence is limited.
Vitamin status, kidney and thyroid function, training and sample handling in the assessment of abnormal homocysteine results.
Appetite, fluid retention, glucose, insulin sensitivity and heart failure signals reported in studies of ibutamoren.
General injection safety, warning signs, medical assessment, drainage and the distinction between an expected reaction and infection.
Heart disease, blood pressure, kidney function and interacting medicines: the evidence and uncertainties behind arginine precautions.
Dietary intake, elemental magnesium, regional upper limits, divided amounts and separation from interacting medicines.
From molecular modifications to gene transcription and muscle protein synthesis, with a clear distinction between evidence and inference.
How cyclosporine, fibrates, antivirals, anticoagulants, antacids and other products can affect rosuvastatin treatment.
A guide to documented adverse effects, levels of evidence, high-risk groups and the limitations of calling stanozolol mild.
Peptide identity, HPLC, mass spectrometry, endotoxins and the limits of certificates and visual checks for unapproved products.
How external testosterone suppresses LH, FSH, testicular function and sperm production, and why recovery after stopping varies.